Cell-Based Assays Market 2018: Dominated by North America, followed by Europe.

Press Release   •   Jan 22, 2018 09:00 EST

The major factors driving this market are the growing funding and investments in R&D, the increasing prevalence of chronic disorders, rising drug discovery activity, and the advantages of cell-based assays over alternative technologies. The cell-based assays market is expected to reach USD 19.92 Billion by 2022 from USD 13.34 Billion in 2017, at a CAGR of 8.4% during the forecast period from 2017 to 2022.

Download sample study for the 165 pages, report here@ http://www.rnrmarketresearch.com/contacts/request-sample?rname=173399

Geographically, the cell-based assays market is dominated by North America, followed by Europe. The Asia-Pacific region is estimated to grow at the fastest rate which can be attributed to the increased investments in the healthcare sector, rising expenditure on healthcare along with increased coverage of health insurance, and a rise in disposable incomes especially in countries like China, Japan, and India.

A number of factors, such as growing funding and investments in R&D, the increasing prevalence of chronic disorders, increase in drug discovery activities, and the advantages of cell-based assays over alternative technologies are expected to drive the growth of this market.

The cell-based assays market is classified on the basis of products into consumables, instruments, services and software. The consumables segment is further segmented into reagents, assay kits, micro plates, cell lines, probes & labels and other consumables. Inquire For Complete Report Copy of Cell-based Assays Market by Product (Reagents, Assay Kits, Microplates, Cell Lines, Service), Application (Research, Drug Discovery, ADME Studies, Toxicology), End User, and Region - Global Forecast to 2022 at http://www.rnrmarketresearch.com/contacts/inquire-before-buying?rname=173399

Cell-Based Assays Market: Competitive Landscape

1 Introduction
2 Market Share Analysis
3 Vendor Dive Overview
Visionary Leaders
Dynamic Differentiators
Emerging Companies
4 Competitive Benchmarking
Business Strategies Adopted By Major Players in the Global Market (25 Players)
Analysis of Product Portfolio of Major Players in the Global Market (25 Players)

Research Coverage:

The report analyses the cell-based assays market by products, applications, end users, and regions. Apart from a comprehensive geographic &product analysis and market sizing, the report also provides the competitive landscape that covers the growth strategies adopted by industry players over the last three years. In addition, the company profiles comprise of product portfolios, developments, and strategies adopted by key players to maintain and increase their shares in the market.

The Most Useful of global Cell-based assays Market Target Audience for this Report:

  • Cell-based assays manufacturers and vendors
  • Research associations related to drug discovery
  • Healthcare providers (hospitals, laboratories, medical schools, and outpatient clinics)
  • Various research and consulting firms
  • Distributors of cell-based assays
  • Academic and Research Institutes

*Top 25 Companies Analysed for This Study are - Becton, Dickinson and Company. (U.S.), Cell Signaling Technology (U.S.), Danahar Corporation (U.S.), Cisbio Bioassays (France), Merck KGaA (Germany), Ge Healthcare (U.K), Discoverx Corporation (U.S.), Thermo Fisher Scientific Inc. (U.S.), Perkinelmer Inc. (U.S.), Promega Corporation (U.S.), Proqinase GmbH (Germany), Charles River Laboratories International, Inc. (U.S.), Marine Biological Laboratory (U.S.), Biospherix, Ltd. (U.S.), Essen Bioscience (U.S.), Miltenyi Biotec (Switzerland), Bioagilytix Labs. (U.S.), Enzo Life Sciences, Inc. (Switzerland), Lonza (Switzerland), Aurelia Bioscience Ltd. (U.K), Selexis Sa (U.S.), Life Technologies Corporation (U.S.), Cell Biolabs, Inc. (U.S.), Biotek Instruments, Inc. (U.S.), Qgel Sa (Switzerland)

Cell-based Assays Market” spread across 165 pages, profiling 25+ companies andsupported with 86 tables and 48 figures is Direct Order this Report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=173399

The Key Points of this study are as follows:

  • To Define, Describe, And Forecast The Cell-Based Assays Market By Product, Application, End User, And Region
  • To Provide Detailed Information Regarding The Major Factors Influencing Growth Of The Market (Drivers, Restraints, And Opportunities)
  • To Analyze Micromarkets With Respect To Individual Growth Trends, Prospects, And Contributions To The Overall Market
  • To Analyze The Opportunities In The Market For Stakeholders And Provide Details Of A Competitive Landscape For Market Leaders
  • To Forecast Revenue Of The Market Segments With Respect To Four Main Regional Segments, Namely, North America, Europe, Asia-Pacific, And The Rest Of The World (Row)
  • To Profile Key Players And Comprehensively Analyze Their Market Shares And Core Competencies In Terms Of Market Developments And Growth Strategies

About Company:

RnRMarketResearch.com is your single source for all market research needs. Our database includes 500,000+ market research reports from over 95 leading global publishers & in-depth market research studies of over 5000 micro markets. With comprehensive information about the publishers and the industries for which they publish market research reports, we help you in your purchase decision by mapping your information needs with our huge collection of reports.

Contact Us

Corporate Headquarters
2nd floor, metropole,
Next to inox theatre,
Bund garden road,
+ 1 888 391 5441 sales@rnrmarketresearch.com